http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012205348-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9121895e2832e9bfc0eb2b90ccd52a23 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1081 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-95 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-07 |
filingDate | 2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ebe55557b9e848ba1608e648fc2e513 |
publicationDate | 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2012205348-B2 |
titleOfInvention | Endoluminal drug applicator and method of treating diseased vessels of the body |
abstract | A stent-graft is coupled to an elongate flexible member at or near the distal end of the flexible member and configurable in both a collapsed configuration and an expanded configuration. The stent-graft includes an expandable stent fixed to the flexible member. A portion of the expandable stent defines a generally tubular structure in its expanded configuration. A porous polymeric mesh interfaces circumferentially about the portion of the stent defines a generally tubular structure. The mesh is expandable with the stent and carries at least one therapeutic agent. When the stent-graft is in its expanded configuration and contacts the treatment site, the at least one therapeutic agent is transferred to the treatment site by operation of contact between the stent-graft and the treatment site. The mesh can define distal and proximal openings that allow for fluid flow through the stent-graft when the stent-graft is in the expanded configuration. |
priorityDate | 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 255.